期刊文献+

生物样品中游离铂与总铂浓度的石墨炉AAS测定 被引量:2

Determination of free and total platinum levels in biological samples by graphite furnace atomic absorption spectroscopy
原文传递
导出
摘要 目的:研究植入用顺铂兔局部给药后生物样品中药物浓度的测定方法,并分别测定游离铂及总铂的浓度。方法:改进石墨炉原子吸收法的升温程序和上样方法;增加生物样品的超滤前处理方法,以去除顺铂的蛋白结合物便于测定游离铂含量;并按《中华人民共和国药典》的规定对测定方法进行验证和评估。结果:本测定方法的回收率为80%-110%,日内精密度(RSD)在5%以下,均符合《中华人民共和国药典》2010年版规定。组织中游离铂浓度约为总铂浓度的10%-30%,静脉血中游离铂浓度是总铂浓度的5%以下。结论:当前建立的石墨炉原子吸收方法能较好地测定出血液和组织样本中的游离铂和总铂浓度,且该方法无爆沸现象、重现性好、灵敏度高、数据准确。 Objective: To determine the free and total platinum levels in biological samples from rabbits treated by cisplatin implant administration. Methods: In this experiment, an improved methods for temperature- programming and loading were introduced, and a uhrafihration technology for removing cisplatin-protein conjugates from biological samples was studied. Then, the measurement method for free and total platinum levels was analyzed and evaluated according to the stands of Chinese Pharmacopoeia. Results: After using this method, the recovery was 80% - ll0% and the intraday precision (RSD) was below 5% , which were entirely consistent with the regu- lations of the Chinese Pharmacopoeia 2010 edition. In tissues, the free platinum level accounted for approximately 10% -30% of the total platinum level, and in the venous blood, the free platinum level was even below 5%. Conclusion : The method for the determination of free and total platinum levels in biological samples by atomic fluo- rescence spectrometry has been developed. The method has good reproducibility, high sensitivity and accuracy. Moreover, no bumping phenomenon has been found.
出处 《中国新药杂志》 CAS CSCD 北大核心 2014年第22期2681-2686,共6页 Chinese Journal of New Drugs
基金 国家科技计划课题(2013BA101B05)
关键词 顺铂 原子吸收分光光度法 横向平台石墨炉 生物样品 cisplatin atomic absorption spectrophotometry horizontal platform graphite furnace biologi- cal samples
  • 相关文献

参考文献10

  • 1BARABS K,MILNER R, LURIE D, et al. Cisplatin : a review oftoxicties and therapeutic applications [ J ]. Vet Comp Oncol ,200S ,6(1) :1 -18.
  • 2BOSCH ME,SANCHEZ AJ,ROJAS ?S,et al. Analytical method-ologies for the determination of cisplatin [ J ] . Pharm Biomed A-na/,2008,47(3) :451 -459.
  • 3储成顶,成微,王世亮,刘飞,俞敏,鲍玉婷.缓释植入剂局部给药治疗系统的药动学模型[J].中国新药杂志,2004,13(7):613-616. 被引量:23
  • 4GUCHEL AAR HJ,DE VRIES EG,MEIJER C,et al. Effect ofultrafilterable platinum concentration on cisplatin and carboplatincytotoxicity in human tumor and bone marroe cells in vitro [ J ].Pharm ftes, 1994 ,11 (9) :1265 - 1269.
  • 5王世亮,叶红杨,马晓芹,许媛媛,储成顶.石墨炉原子吸收光谱法测定血浆中铂[J].理化检验(化学分册),2010,46(3):257-259. 被引量:5
  • 6VERMORKEN JB,VAN DER VIJGH WJ,KLEIN \,et al. Phar-macokinetics of free and total platinum species after rapid andprolonged infusions of cisplatin[ J]. Clin Pharmacol Ther,1986 ,39(2) :136 -144.
  • 7GAMELIN E, ALLAIN P, MAILLART P, et al. Long-term phar-macokinetic behaxior of Platinum after cisplatin administration[J]. Cancer Chemother Pharmacol, 1995 ,37(1 -2):97 - 102.
  • 8SIDDIK ZH , CISPLATIN. Mode of cytotoxic action and molecularbasis of resistance [ J ]. Oncogene, 2003 ,22 (47 ) :7265 - 7279.
  • 9UMMAT A,RECHKOBLIT 0,JAIN R,ef al. Structural basis forcisplatin DNA damage tolerance by human polymerase eta duringcancer chemotherapy [ J ]. Nat Struct Mol Biol, 2012,19(6):628 -632.
  • 10沈子威,王昶,沈淑敏.抗癌药物顺铂对DNA结构的影响[J].生物物理学报,1990,6(2):275-280. 被引量:1

二级参考文献16

  • 1姜启源.数学模型[M].北京:高等教育出版社,1999..
  • 2VEAL G J, DIAS C, PRICE L, et al. Influence of cellular factors and pharmacokinetics on the formation of platinum-DNA adducts in leukocytes of children receiving cisplatin therapy[J]. Clin Cancer Res, 2001,7 (8) :2205-2212.
  • 3LOPEZ-FLORES A, JURADO R, GARCIA-LOPEZ P. A high-performance liquid chromatographic assay for determination of cisplatin in plasma, cancer cell, and tumor samples[J]. J Pharmacol Toxicol Methods, 2005,52(3) :366-372.
  • 4LANJWANI S N, ZHU R, KHUHAWAR M Y, et al. High performance liquid chromatographic determination of platinum in blood and urine samples of cancer patients after administration of cisplatin drug using solvent extraction and N, N'-bis(salicylidene)-1, 2-propanediamine as complexation reagent[J]. J Pharm Biomed Anal, 2006,40(4):833-839.
  • 5GELEVERT T, MESSERSCHMIDT J, MAEINAR- DI M T, et al. Adsorptive voltametry to determine platinum levels in plasma from testicular cancer patients treated with cisplatin[J]. Ther Drug Monit, 2001,23(2) : 169-173.
  • 6HUANG Z, TIMERBAEV A R, KEPPLER B K, et al. Determination of cisplatin and its hydrolytic metabolite in human serum by capillary electrophoresis techniques[J]. J Chromatogr A, 2006,1106(1/2) :75-79.
  • 7PENDYALA L, SCHWARTZ G, SMITH P, et al. Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy[J]. Cancer Chemother Pharmacol, 2003, 51 (5) : 376-384.
  • 8ZAMBONI W C, GERVAIS A C, EGORIN M J, et al. Inter-and intratumoral disposition of platinum in solid tumors after administration of cisplatin[J]. Clin Cancer Res, 2002,8(9) : 2992-2999.
  • 9[5]梁秉文.经皮给药制剂[M].中国医药科技出版社,1996.55-78.
  • 10[8]储成顶,童小萍,许健健,等.Study onlocal plasma durg concentration-space-tim equation at local embedding [J ]. Asian J Drug Metabol Pharmacokinet, 2003,3 ( 1 ): 25 - 36.

共引文献26

同被引文献19

引证文献2

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部